US OptionsDetailed Quotes

SAVA241108P27500

Watchlist

3.48
-0.14-3.87%

15min DelayClose Nov 5 16:00 ET

3.48High3.48Low

Cassava Sciences Stock Discussion

JAYYFLASH

1 hour ago

$Cassava Sciences (SAVA.US)$ Shorts are full of crap and the real manipulators of the stock price and market. First they made false statements by saying that Matt N. sold shares which he denied and put out a statement to rebuke them. Yesterday, the shorts falsely stated that Remi sold shares when in fact the 13G Filing was the options expiring, He didn't sell. These Tactics that the shorts have used to short the stock price with naked shorting along the daily shorting for 4 years are illegal in e...

JAYYFLASH

7 hours ago

$Cassava Sciences (SAVA.US)$ New Article Today 11/05/24: This again shows how important Filamin A is. SAVA definitely has a Breakthrough. "The British Heart Foundation’s Reflections of Research competition showcases beautiful images captured by researchers studying heart and circulatory disease. The image above shows a cell collected from the heart of a person with an irregular heartbeat due to a condition called atrial fibrillation (AF). The glowing strands of orange and yellow highlight a prote...

JAYYFLASH

Nov 3 13:15

$Cassava Sciences (SAVA.US)$ The Facts are that ever since SAVA's approach for repairing misfolded protein as oppose to removing amyloid plaque from the brain that the other companies have focussed on for decades that cause brain damage and brain swelling, More studies are coming out from others that Wider Impact on Brain Health: By improving protein folding and cellular health more broadly, repairing misfolded proteins might benefit overall neuron function & other chronic & debilitating diseases...

JAYYFLASH

Oct 31 13:47

$Cassava Sciences (SAVA.US)$ The News of SAVA discovering the benefits of Filamin A was too great to be denied and more benefits of Filamin A discovered: Published:Oct 25, 2024
"filamin A levels in serum could effectively differentiate between benign prostatic hyperplasia and prostate cancer, providing a more specific indicator than traditional PSA tests. The test was shown to be effective across various ethnicities."

JAYYFLASH

Oct 31 08:36

$Cassava Sciences (SAVA.US)$ Institution Loaded Up with 10 Million bucks. More big believers that SAVA is going to improve AD patient lives. ´The institutional investor purchased 36,052 shares of the company's stock, valued at approximately $10,610,000´

JAYYFLASH

Oct 31 07:57

$Cassava Sciences (SAVA.US)$ Bullish News Coming:Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
Conference call and webcast to begin at 8:30 AM ET

JAYYFLASH

Oct 30 11:24

$Cassava Sciences (SAVA.US)$ The SEC & DOJ has allowed manipulation on SAVA stock by Short Sellers with fake shares and yet retail and other investors have had to use real money to buy the stock. There are many FTDS & complaints to SEC for years about tis and yet they have done nothing. SEC took 40 Million and let them continue to do this. Now, it must and will stop as SAVA finished Phase 3 trials, Lawyers have exposed the unorganized, unethical statute of limitations against Wang by DOJ and all ...

JAYYFLASH

Oct 28 09:42

$Cassava Sciences (SAVA.US)$ More reasons to be Bullish on SAVA. Early trials of simufilam have shown encouraging results, with improvements in cognition and behavior in patients after six months of treatment. Furthermore, the drug reduced inflammatory cytokine production in lab models, highlighting its potential as both a neuroprotective agent and a way to prevent disease progression.
Given these findings, restoring FLNA function could be a promising therapeutic strategy for AD, supporting vascu...

Trading_HT

Oct 23 12:30

SAVA Stock Analysis +200% since June! Cassava Sciences Trading Technical Analysis - 2024-2025

$Cassava Sciences (SAVA.US)$

https://youtu.be/YhSvE-IZ8WI

From YouTube

Night Pig

Oct 23 11:33

$Cassava Sciences (SAVA.US)$ Here is a link to Matt Nachtrabs summary of Cassava. Definitely a convincing read for those who are skeptical.
x.com

No comment yet